证券记录 · 已归档季度
PRGO
Perrigo Company plc · Healthcare · Drug Manufacturers - Specialty & Generic
19被追踪持有人
0Δ持有人
63.63M持有股份
$1.42B报告持仓市值
+1新建仓位
−2清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +7.0% · 净新建仓位 -5.3% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | +1 | 170.32K | $2.41M | +1 | n/a |
| Q2 2026 | 100 | +3 | 113.08M | $1.17B | +10 | −8 |
| Q1 2026 | 101 | +4 | 101.94M | $1.09B | +11 | −8 |
| Q4 2025 | 98 | -2 | 106.62M | $1.48B | +3 | −4 |
| Q3 2025 | 19 | 0 | 63.63M | $1.42B | +1 | −2 |
| Q2 2025 | 17 | 0 | 58.29M | $1.56B | n/a | n/a |
| Q1 2025 | 14 | +1 | 29.73M | $833.59M | +1 | n/a |
| Q4 2024 | 13 | -2 | 24.99M | $642.39M | n/a | −2 |
| Q3 2024 | 14 | -1 | 13.07M | $342.69M | n/a | −1 |
| Q2 2024 | 15 | n/a | 10.85M | $278.70M | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | T. Rowe Price ✦ | 16.92M | +16.3% | $376.82M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 2 | The Vanguard Group ✦ (被动) | 13.88M | -1.0% | $309.16M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | BlackRock ✦ (被动) | 13.48M | +2.6% | $300.10M | 0.0% | ▲ Add | 2 | SEC ↗ ×16 |
| 4 | State Street Global Advisors ✦ (被动) | 6.90M | -6.0% | $153.73M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Millennium Management ✦ | 3.17M | +279.9% | $70.55M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 6 | Geode Capital Management ✦ (被动) | 2.72M | +10.6% | $60.48M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Wellington Management ✦ | 2.05M | +2.5% | $45.67M | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 8 | Morgan Stanley ✦ | 1.48M | n/a | $32.97M | 0.0% | n/c | 1 | SEC ↗ ×9 |
| 9 | GAMCO Investors ✦ | 855.50K | -4.9% | $19.05M | 0.2% | ▼ Trim | 6 | SEC ↗ |
| 10 | Goldman Sachs Group ✦ | 576.75K | n/a | $12.84M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | JPMorgan Chase ✦ | 523.49K | n/a | $11.66M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 12 | Arrowstreet Capital ✦ | 517.77K | +60.2% | $11.53M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Renaissance Technologies ✦ | 259.00K | -37.6% | $5.77M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 182.54K | -54.9% | $4.07M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 15 | D. E. Shaw & Co. ✦ | 67.03K | 新增 | $1.49M | 0.0% | New | 1 | SEC ↗ ×2 |
| 16 | AQR Capital Management ✦ | 25.46K | +17.4% | $553,668 | 0.0% | ▲ Add | 6 | SEC ↗ ×3 |
| 17 | Gotham Asset Management ✦ | 14.55K | -88.5% | $324,051 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Marshall Wace ✦ | 9.14K | +19.5% | $203,525 | 0.0% | ▲ Add | 6 | SEC ↗ |
| 19 | Fidelity (FMR) ✦ | 2.06K | -99.4% | $45,813 | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| D. E. Shaw & Co. | $1.49M | 0.0% |
已清仓
| Norges Bank | $36.75M | 曾为 0.0% |
| Two Sigma Investments | $766,276 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 326 持有人, 151.12M 股份, $1.41B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
Sep 08
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Aug 14
SC 13G/A: PRICE T ROWE ASSOCIATES INC /MD/
Jul 29
SC 13G/A: BlackRock, Inc.
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据